This startup wants to accelerate ‘precision medicine’ with its growing biological data platform

(Amplion Screenshot)

Amplion, a startup that helps healthcare companies sort through biological data, closed a Series A fundraising round led by Greycroft with participation from existing investors Revolution’s Rise of the Rest Seed Fund and Imagen Capital Partners. The Bend, Ore.-based company plans to put the fresh cash

This post was originally published on this site


Check out